However, RhoA FRET was significantly greater with agonist stimulation of neuropathy mutant TRPV4, with more rapid onset, longer duration, and higher peak RhoA activation (Fig. 5c–e and Supplementary Movie 2). The gene discussed is RHOA; the disease is neuropathy.